Company news
Sophia Genetics Sa (NASDAQ:SOPH) news
Sophia Genetics Sa news releases on 6ix. Latest, Sep 7, 2023: SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live…
Press releases — page 3
SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform
September 6, 2023
CHU Bordeaux is live on SOPHiA GENETICS
August 29, 2023
SOPHiA GENETICS Expands Relationship with Gustave Roussy
August 21, 2023
A.O.U. San Giovanni di Dio Ruggi d'Aragona Expands Usage of SOPHiA GENETICS DDM™ Platform
August 16, 2023
Tulane University School of Medicine Uses SOPHiA GENETICS to Advance Research of Blood Cancers
August 7, 2023
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023
August 7, 2023
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2023 on August 8, 2023
July 24, 2023
SOPHiA GENETICS Announces Gruppo Centro Servizi Medici (CSM) is Live on the SOPHiA DDM™ Platform
July 12, 2023
Centre Hospitalier de Bastia is Live on SOPHiA GENETICS
July 6, 2023
SOPHiA GENETICS Publishes Results of 2023 Annual General Meeting
June 25, 2023
Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform
June 21, 2023
NOMAD Genetics is Live on the SOPHiA GENETICS Platform
June 14, 2023
SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research
June 1, 2023
SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors
May 30, 2023
Institute of Oncology Ljubljana Leverages SOPHiA DDM™ Platform for Cancer Research
May 23, 2023
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023
May 8, 2023
SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is Tapped by Unipath Specialty Laboratory Limited
May 2, 2023
SOPHiA GENETICS Celebrates Swiss Biotech Award
April 24, 2023
Tel Aviv Sourasky Medical Center Chooses SOPHiA DDMTM HRD Solution of SOPHiA GENETICS
April 3, 2023
SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results
March 6, 2023
SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022
November 7, 2022
SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis
October 31, 2022
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
September 20, 2022
SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022
September 19, 2022
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
August 8, 2022
SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
August 3, 2022
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
July 13, 2022
SOPHiA GENETICS Launches New Solution to Advance Chronic Lymphocytic Leukemia Care, in Collaboration with IDIBAPS
June 8, 2022
SOPHiA GENETICS Announces Three Poster Presentations and One Online Publication Accepted at the 2022 American Society of Clinical Oncology Annual (ASCO) Meeting
May 31, 2022
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022
May 9, 2022
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors
May 4, 2022
SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform
April 25, 2022
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
April 12, 2022
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
March 14, 2022
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
March 8, 2022
SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies
February 23, 2022
SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
February 15, 2022
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer
January 25, 2022
SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study
January 10, 2022
SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study
November 30, 2021
SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021
November 28, 2021
SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance
November 9, 2021
SOPHiA GENETICS Launches SOPHiA DDM™ for SureSelect Human All Exon v8
October 31, 2021
SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021
October 26, 2021
SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance
September 8, 2021
SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
August 25, 2021
SOPHiA GENETICS Announces Closing of $234 Million Initial Public Offering and $20 Million Private Placement
July 26, 2021
SOPHiA GENETICS Announces Pricing of Initial Public Offering
July 21, 2021